These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades. Benowitz NL; Jones RT Clin Pharmacol Ther; 1977 Mar; 21(3):336-42. PubMed ID: 837652 [TBL] [Abstract][Full Text] [Related]
3. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Kanakis C; Pouget JM; Rosen KM Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395 [TBL] [Abstract][Full Text] [Related]
9. Effects of delta9-tetrahydrocannabinol and cannabinol in man. Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432 [TBL] [Abstract][Full Text] [Related]
10. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects. Pabon E; Rockwood F; Norman GJ; de Wit H Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of nabilone, a cannabinol derivative. Lemberger L; Rowe H Clin Pharmacol Ther; 1975 Dec; 18(6):720-6. PubMed ID: 1204278 [TBL] [Abstract][Full Text] [Related]
12. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat. Adams MD; Chait LD; Earnhardt JT Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665 [TBL] [Abstract][Full Text] [Related]
13. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol. Pertwee RG Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752 [TBL] [Abstract][Full Text] [Related]
14. Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics. Johnstone RE; Lief PL; Kulp RA; Smith TC Anesthesiology; 1975 Jun; 42(6):674-84. PubMed ID: 48348 [TBL] [Abstract][Full Text] [Related]
15. Lack of cardiovascular effects of delta-9-tetrahydrocannabinol in chemically denervated men. Kanakis C; Pouget M; Rosen KM Ann Intern Med; 1979 Oct; 91(4):571-4. PubMed ID: 484957 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man. Benowitz NL; Jones RT J Clin Pharmacol; 1981; 21(S1):214S-223S. PubMed ID: 6271827 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of cannabinol during oral surgery. Gregg JM; Campbell RL; Levin KJ; Ghia J; Elliott RA Anesth Analg; 1976; 55(2):203-13. PubMed ID: 769605 [TBL] [Abstract][Full Text] [Related]
18. Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol. Benowitz NL; Jones RT Clin Pharmacol Ther; 1977 Sep; 22(3):259-68. PubMed ID: 891094 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats. Kawasaki H; Watanabe S; Ueki S Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621 [TBL] [Abstract][Full Text] [Related]
20. Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats. Kawasaki H; Watanabe S; Oishi R; Ueki S Jpn J Pharmacol; 1980 Aug; 30(4):493-502. PubMed ID: 6259394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]